Connect with us

Hi, what are you looking for?

Jewish Business News


“Even at $100 per share Teva’s Mylan bid worthwhile”

Julius Baer analyst Lilian Montero insists it’s illogical for Mylan to remain independent.

Erez Vigodman,   Teva


“Mylan Laboratories is a good acquisition target for Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA), and in my opinion, Teva’s shareholders will welcome it, but it also depends on the price Teva has to pay for Mylan shares, ” says Lilian Montero, an analyst for Swiss investment bank Julius Baer. Montero, who covers the Teva and Mylan shares, believes that Teva management “is taking interesting measures, and with the acquisition of Mylan, the company will be in a better position.”

Teva is seeking to acquire Mylan in a deal totaling over $40 billion ($82 per Mylan share). Mylan, which is opposing the takeover, wants to acquire Perrigo Company (NYSE:PRGO; TASE:PRGO) in a deal worth over $30 billion, but Perrigo also does not want to be acquired. According to Montero, Teva’s proposed acquisition of Mylan will add to its profit even at $100 per Mylan share…  [READ MORE]

Please help us out :
Will you offer us a hand? Every gift, regardless of size, fuels our future.
Your critical contribution enables us to maintain our independence from shareholders or wealthy owners, allowing us to keep up reporting without bias. It means we can continue to make Jewish Business News available to everyone.
You can support us for as little as $1 via PayPal at
Thank you.


GLOBES logo-eng (1) Published by Globes [online], Israel business news –



You May Also Like

World News

In the 15th Nov 2015 edition of Israel’s good news, the highlights include:   ·         A new Israeli treatment brings hope to relapsed leukemia...


The Movie The Professional is what made Natalie Portman a Lolita.


After two decades without a rating system in Israel, at the end of 2012 an international tender for hotel rating was published.  Invited to place bids...

VC, Investments

You may not become a millionaire, but there is a lot to learn from George Soros.